Gold vs US Dollar

Register for real-time alerts, custom portfolio, and market movers

Get Started

Home
Investing
Stocks
USA
NASDAQ
Vistagen Therapeutics Inc (VTGN)
Vistagen Therapeutics Inc (VTGN) Financials

VTGN Vistagen Therapeutics Inc

2.60

0.35 (15.56%)

21 Dec 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 March 2024	2017	2018	2019	2020	2021	2022	2023	2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-494.428	-207.805	-203.48	-222.786	-74.211	-53.255	-123.779	-40.571
Return on Equity (%)	984.668	-413.569	-367.808	-3274.591	-98.134	-62.17	-154.302	-46.471
Return on Invested Capital (%)	848.242	-380.904	-353.113	-4602.662	-42.069	-61.438	-157.19	-52.911
Operating Margin (%)	-819.92	N/A	N/A	N/A	-1645.046	-4306.492	26097.797	-2759.211
Net Profit Margin (%)	-929.92	N/A	N/A	N/A	-3882.569	-4392.065	26100.441	-2759.586
Book Value Per Share	0.046	0.256	0.152	-0.107	0.498	0.307	0.057	3.69
Earnings Per Share	-0.873	-0.576	-0.552	-0.413	-0.229	-0.231	-0.281	-0.948
Cash Per Share	0.219	0.384	0.281	0.025	0.559	0.324	0.079	3.847
Working Capital Per Share	0.151	0.354	0.233	-0.022	0.541	0.31	0.061	3.73
Operating Profit Per Share	0.094	N/A	N/A	N/A	0.006	0.005	-0.001	0.034
EBIT Per Share	-0.77	-0.53	-0.528	-0.39	-0.097	-0.227	-0.281	-0.948
EBITDA Per Share	-0.77	-0.53	-0.528	-0.39	-0.097	-0.227	-0.281	-0.948
Free Cash Flow Per Share	-0.859	-0.579	-0.55	-0.415	-0.228	-0.231	-0.281	-0.95

Liquidity Ratios

Year End 31 March 2024	2017	2018	2019	2020	2021	2022	2023	2024
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	8.84M	23.07M	42.62M	49.35M	180.62M	206.54M	N/A	N/A

Key Stats and Ratios

Year End 31 March 2024	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	206.84M	206.92M	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	N/A	N/A	-3876.404	N/A	N/A	N/A	-12777.381
Net Profit Margin (%)	N/A	N/A	N/A	-3878.09	N/A	N/A	N/A	-12777.381
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	62.65M
Price to Earnings Ratio	-2.37
Price to Sales Ratio	65.45
Price to Cash Ratio	0.58
Price to Book Ratio	0.61
Dividend Yield	-

Share Statistics

Shares Outstanding	27.84M
Average Volume (1 week)	305.46k
Average Volume (1 Month)	231.3k
52 Week Change	-51.31%
52 Week High	5.86
52 Week Low	2.22

More Ratios Coming Soon!

Vistagen Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions